Schelling P - Search Results

1

Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives.

Mederski WW, Dorsch D, Bokel HH, Beier N, Lues I, Schelling P. Mederski WW, et al. Among authors: schelling p. J Med Chem. 1994 May 27;37(11):1632-45. doi: 10.1021/jm00037a014. J Med Chem. 1994. PMID: 8201597

2

Endothelin antagonists: discovery of EMD 122946, a highly potent and orally active ETA selective antagonist.

Mederski WW, Dorsch D, Osswald M, Anzali S, Christadler M, Schmitges CJ, Schelling P, Wilm C, Fluck M. Mederski WW, et al. Among authors: schelling p. Bioorg Med Chem Lett. 1998 Jul 7;8(13):1771-6. doi: 10.1016/s0960-894x(98)00301-1. Bioorg Med Chem Lett. 1998. PMID: 9873432

3

Pharmacological basis for antihypertensive therapy with a novel dopamine agonist.

Haeusler G, Lues I, Minck KO, Schelling P, Seyfried CA. Haeusler G, et al. Among authors: schelling p. Eur Heart J. 1992 Sep;13 Suppl D:129-35. doi: 10.1093/eurheartj/13.suppl_d.129. Eur Heart J. 1992. PMID: 1356783 Review.

4

Involvement of ATP-sensitive potassium channels in preconditioning protection.

Rohmann S, Weygandt H, Schelling P, Kie Soei L, Verdouw PD, Lues I. Rohmann S, et al. Among authors: schelling p. Basic Res Cardiol. 1994 Nov-Dec;89(6):563-76. doi: 10.1007/BF00794956. Basic Res Cardiol. 1994. PMID: 7702545

5

In vivo evidence of positive inotropism of EMD 57033 through calcium sensitization.

Haeusler G, Jonas R, Minck KO, Schliep HJ, Schelling P, Weygandt H, Lues I. Haeusler G, et al. Among authors: schelling p. J Cardiovasc Pharmacol. 1997 May;29(5):647-55. doi: 10.1097/00005344-199705000-00013. J Cardiovasc Pharmacol. 1997. PMID: 9213208

6

Effect of bimakalim (EMD 52692), an opener of ATP sensitive potassium channels, on infarct size, coronary blood flow, regional wall function, and oxygen consumption in swine.

Rohmann S, Weygandt H, Schelling P, Soei LK, Becker KH, Verdouw PD, Lues I, Häusler G. Rohmann S, et al. Among authors: schelling p. Cardiovasc Res. 1994 Jun;28(6):858-63. doi: 10.1093/cvr/28.6.858. Cardiovasc Res. 1994. PMID: 7923292

7

Modulatory role of food, feeding regime and physical exercise on body weight and insulin resistance.

Kretschmer BD, Schelling P, Beier N, Liebscher C, Treutel S, Krüger N, Scholz HP, Haus A. Kretschmer BD, et al. Among authors: schelling p. Life Sci. 2005 Feb 18;76(14):1553-73. doi: 10.1016/j.lfs.2004.08.028. Epub 2004 Dec 22. Life Sci. 2005. PMID: 15680166

8

A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered before or after coronary artery occlusion.

Gumina RJ, Mizumura T, Beier N, Schelling P, Schultz JJ, Gross GJ. Gumina RJ, et al. Among authors: schelling p. J Pharmacol Exp Ther. 1998 Jul;286(1):175-83. J Pharmacol Exp Ther. 1998. PMID: 9655858

9

Inhibitors of ischemic preconditioning do not attenuate Na+/H+ exchange inhibitor mediated cardioprotection.

Gumina RJ, Beier N, Schelling P, Gross GJ. Gumina RJ, et al. Among authors: schelling p. J Cardiovasc Pharmacol. 2000 Jun;35(6):949-53. doi: 10.1097/00005344-200006000-00019. J Cardiovasc Pharmacol. 2000. PMID: 10836732

10

Na(+)/H(+) exchange inhibition prevents endothelial dysfunction after I/R injury.

Gumina RJ, Moore J, Schelling P, Beier N, Gross GJ. Gumina RJ, et al. Among authors: schelling p. Am J Physiol Heart Circ Physiol. 2001 Sep;281(3):H1260-6. doi: 10.1152/ajpheart.2001.281.3.H1260. Am J Physiol Heart Circ Physiol. 2001. PMID: 11514295 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters